Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ivy Carroll

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Molecular Pharmacology|June 13, 2006
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptorsKarla B Mihalak, F Ivy Carroll, Charles W Luetje
Psychopharmacology|October 31, 2002
Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in ratsKabirullah Lutfy, Imran Khaliq, F Ivy Carroll, et al.
Bioorganic & Medicinal Chemistry|June 17, 2008
Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanesChunyang Jin, Hernán A Navarro, Kevin Page, et al.
Neuropharmacology|June 6, 2015
Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in miceKia J Jackson, Asti Jackson, F Ivy Carroll, et al.
Behavioural Pharmacology|April 1, 1992
Stimulus generalization from cocaine to analogs with high in vitro affinity for dopamine uptake sitesE.J. Cline, P. Terry, F. Ivy Carroll, et al.
Synapse (New York, N.Y.)|February 9, 2002
Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter bindingRichard B Rothman, Christina M Dersch, F Ivy Carroll, et al.
Journal of Medicinal Chemistry|September 1, 2006
Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptorJames B Thomas, Li Zhang, Hernan A Navarro, et al.
British Journal of Pharmacology|February 20, 2009
Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporterHernán A Navarro, James L Howard, Gerald T Pollard, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2012
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain modelsShakir D AlSharari, F Ivy Carroll, J Michael McIntosh, et al.
Experimental and Clinical Psychopharmacology|October 26, 2011
Influence of chronic dopamine transporter inhibition by RTI-336 on motor behavior, sleep, and hormone levels in rhesus monkeysMonica L Andersen, Eileen K Sawyer, F Ivy Carroll, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Molecular Pharmacology|June 13, 2006
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptorsKarla B Mihalak, F Ivy Carroll, Charles W Luetje
Psychopharmacology|October 31, 2002
Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in ratsKabirullah Lutfy, Imran Khaliq, F Ivy Carroll, et al.
Bioorganic & Medicinal Chemistry|June 17, 2008
Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanesChunyang Jin, Hernán A Navarro, Kevin Page, et al.
Neuropharmacology|June 6, 2015
Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in miceKia J Jackson, Asti Jackson, F Ivy Carroll, et al.
Behavioural Pharmacology|April 1, 1992
Stimulus generalization from cocaine to analogs with high in vitro affinity for dopamine uptake sitesE.J. Cline, P. Terry, F. Ivy Carroll, et al.
Synapse (New York, N.Y.)|February 9, 2002
Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter bindingRichard B Rothman, Christina M Dersch, F Ivy Carroll, et al.
Journal of Medicinal Chemistry|September 1, 2006
Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptorJames B Thomas, Li Zhang, Hernan A Navarro, et al.
British Journal of Pharmacology|February 20, 2009
Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporterHernán A Navarro, James L Howard, Gerald T Pollard, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2012
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain modelsShakir D AlSharari, F Ivy Carroll, J Michael McIntosh, et al.
Experimental and Clinical Psychopharmacology|October 26, 2011
Influence of chronic dopamine transporter inhibition by RTI-336 on motor behavior, sleep, and hormone levels in rhesus monkeysMonica L Andersen, Eileen K Sawyer, F Ivy Carroll, et al.
Pageof 19